Cibus, Inc. Appoints Craig Wichner as Chief Executive Officer in Major Leadership Overhaul
Key Highlights
- Craig Wichner, a Cibus board member since November 2024, has been appointed Chief Executive Officer (CEO), effective June 8, 2026.
- Peter Beetham, who served as Interim CEO since February 2025, returns to his prior role as President and Chief Operating Officer (COO).
- Both Wichner and Beetham resigned from the Cibus Board of Directors as part of the reorganization.
- The number of directors on the Board was reduced to seven following these departures.
- Wichner’s compensation package includes a \$650,000 base salary, eligibility for annual bonus and long-term equity incentives, and a substantial new equity grant.
- The leadership transition follows a successful period where Cibus raised over \$62 million in new investments and nears its commercialization targets.
Details of the Leadership Changes
Cibus, Inc. (Nasdaq: CBUS), a leader in agricultural biotechnology and plant trait development, announced a significant leadership change as part of its previously announced succession plan. The company has appointed Craig Wichner as its new Chief Executive Officer, effective June 8, 2026. This move comes as the company positions itself at a pivotal point, ready to execute on near-term commercialization targets and drive long-term value creation.
Mr. Wichner, who joined Cibus’ Board of Directors in November 2024, brings a deep blend of financial expertise, strategic discipline, and operational insight. He is known for his experience leading Farmland LP, a major U.S. farmland investment management firm with more than \$350 million in assets and over 18,000 acres under management. Wichner has a track record of demonstrating how regenerative and organic farming practices can drive both strong financial performance and measurable environmental outcomes.
Concurrent with this appointment, Peter Beetham—who has been serving as Interim CEO since February 2025—will return to his position as President and Chief Operating Officer, a role he has held since June 2023. Both Mr. Wichner and Dr. Beetham have also resigned from the Board of Directors as part of the company’s reorganization plan. The Board now stands at seven members.
Details of Wichner’s Employment Agreement
- Base Salary: \$650,000 per annum.
- Incentives: Eligible for discretionary annual bonus and annual incentive equity awards, as determined by the Board or Compensation Committee.
- Benefits: Participation in all employee benefit plans, including retirement, profit sharing, insurance, and welfare plans.
- Equity Grants: On June 8, 2026, Wichner received a restricted stock unit (RSU) award and a stock option award, each with a grant date fair value of \$1,100,000, vesting in four equal annual installments. The options have a ten-year term and an exercise price set at fair market value on the grant date.
- Severance: If terminated without cause or if he resigns for good reason, Wichner is entitled to 18 months of base salary, vesting of equity that would have vested during that period, payment of any earned but unpaid bonus, and up to 18 months of company-paid COBRA premiums.
- Change in Control: Similar severance benefits apply in the event of a qualifying change in control.
- Receipt of severance is subject to execution of a release of claims.
Market-Sensitive and Shareholder-Relevant Points
- Strategic Execution: Wichner’s appointment signals a focus on operational discipline and commercialization, key to unlocking Cibus’ growth potential and enhancing shareholder value.
- Succession Plan: The new CEO has been part of the company’s strategic planning as a board member, providing continuity and reducing leadership transition risk.
- Recent Fundraising: Under Beetham’s interim leadership, Cibus raised over \$62 million, improving its financial footing as it approaches commercialization milestones.
- Potential for Share Price Movement: The appointment of a seasoned executive with a strong track record in both finance and sustainable agriculture, combined with the company’s imminent commercialization efforts, could be price-sensitive. Investors may interpret these changes as a sign of increased execution capability and improved long-term prospects for Cibus.
- No Related Party Transactions: There are no arrangements or family relationships between Wichner and other directors or executives, and no related-party transactions requiring disclosure.
Statements from Leadership
Mark Finn, Chairman of the Board: “With his proven track record of delivering results and creating value, and his demonstrated leadership capabilities, including through his time on the Board, we are confident Craig is the right person to lead Cibus forward in our next stage as we focus on execution of the Company’s near-term commercialization targets.”
Craig Wichner, CEO: “My immediate focus is execution: getting Cibus’ improved traits into customers’ hands, converting our near-term commercialization targets into revenue, and maintaining the capital discipline to get there. Cibus is at a pivot point of real opportunity, and I am honored to lead it.”
Peter Beetham, President & COO: “It is a pivotal moment for Cibus and I believe Cibus is fortunate to have Craig lead us into this next phase of growth, and I am excited to work with him.”
Investor Takeaways
- This leadership transition comes as Cibus approaches key commercialization milestones that could have material impact on its financial performance and share price.
- Wichner’s compensation package aligns his interests with those of shareholders, providing strong incentives for performance and value creation.
- Investors should monitor the company’s progress toward these targets, as successful execution could drive significant upside.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Readers should consult their own advisors and review all relevant filings and disclosures before making any investment decisions. The information provided may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected. Cibus, Inc. undertakes no obligation to update forward-looking statements, except as required by law.
